GlaxoSmithKline (CAI:BIOC) FCF Margin %: 24.03% (As of Sep. 2016)


What is GlaxoSmithKline FCF Margin %?

GlaxoSmithKline CAI:BIOC +1.17% FCF Margin % is 24.03% as of Sep. 2016.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GlaxoSmithKline's Free Cash Flow for the three months ended in Sep. 2016 was E£64 Mil. GlaxoSmithKline's Revenue for the three months ended in Sep. 2016 was E£268 Mil. Therefore, GlaxoSmithKline's FCF Margin % for the quarter that ended in Sep. 2016 was 24.03%.

As of today, GlaxoSmithKline's current FCF Yield % is 0.00%.

The historical rank and industry rank for GlaxoSmithKline's FCF Margin % or its related term are showing as below:

CAI:BIOC' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.84
Current: 0.84

During the past 4 years, the highest FCF Margin % of GlaxoSmithKline was 0.84%. The lowest was 0.00%. And the median was 0.00%.

CAI:BIOC's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.48 vs CAI:BIOC: 0.84

GlaxoSmithKline FCF Margin % Related Terms

GlaxoSmithKline FCF Margin % Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline FCF Margin % Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
FCF Margin %
14.10 23.74 15.53 12.06

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.54 38.02 -48.67 -10.90 24.03

CAI:BIOC vs PRPH: FCF Margin % Comparison

For the Drug Manufacturers - General subindustry, GlaxoSmithKline's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline's FCF Margin % falls into.


GlaxoSmithKline FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GlaxoSmithKline's FCF Margin for the fiscal year that ended in Dec. 2015 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=123.144/1020.948
=12.06 %

GlaxoSmithKline's FCF Margin for the quarter that ended in Sep. 2016 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2016 )/Revenue (Q: Sep. 2016 )
=64.333/267.715
=24.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 24.03% mean?
GlaxoSmithKline (CAI:BIOC) has a FCF Margin % of 24.03% as of Sep. 2016. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's FCF Margin % too high?
GlaxoSmithKline's current FCF Margin % is 24.03%. The Drug Manufacturers industry median FCF Margin % is 2.48. GlaxoSmithKline's value of 24.03% is 869% above this industry median.
How does GlaxoSmithKline's FCF Margin % compare to PRPH?
GlaxoSmithKline's FCF Margin % of 24.03% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.48. GlaxoSmithKline's value of 24.03% is 869% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GlaxoSmithKline's current FCF Margin % of 24.03% is 869% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GlaxoSmithKline and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline's current FCF Margin % is 24.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current FCF Margin % of 24.03%. The current FCF Margin % is 24.03% and 869% above the Drug Manufacturers industry median of 2.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current FCF Margin % is 24.03% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.